Anti-exosmosis chemotherapy dosing device for medical oncology

By using trapezoidal rubber blocks and medical fixing belts in the doser, and using the collection module of the receiver to collect residual drug liquid after injection, the problems of drug extravasation and secondary dripping are solved, and the injection stability and administration effect are improved.

CN120037516APending Publication Date: 2025-05-27CHONGQING UNIV CANCER HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510155942.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-02-12
Publication Date
2025-05-27

AI Technical Summary

Technical Problem

When the existing drug delivery device is injected with chemotherapy drugs, extravasation is caused by the patient's body shaking, causing part of the drug to come into contact with the skin, causing skin damage and reduced chemotherapy effect. At the same time, the residual drug liquid after injection has secondary dripping due to the influence of the pull-out force, which cannot completely prevent extravasation.

Method used

An anti-extravasive chemotherapy drug delivery device is designed, which includes a combination of a trapezoidal rubber block and a medical fixing belt, and stably position the injection needle through the bonding contact of the rubber block to avoid drug extravasation; after the injection, the collection module of the receiver body is inserted inclinedly into the side of the rubber block, and the collection tank of the collection module comes into contact with the lower end of the injection needle tube to collect residual drug liquid to avoid secondary dripping.

Benefits of technology

It effectively avoids drug extravasation and skin damage, improves the stability of drug injection and the effectiveness of the use of the drug delivery device, and ensures the complete collection of the drug solution, avoids adverse reactions caused by secondary dripping.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120037516A_ABST
    Figure CN120037516A_ABST
Patent Text Reader

Abstract

The invention provides an anti-exosmosis chemotherapy drug delivery device for medical oncology, which structurally comprises a drug delivery structure, the center of the upper end of the drug delivery structure is fixedly connected with the lower end of a hose, and the upper end of the hose is in airtight communication with the lower end of a guide module; the top of the guide module is embedded into the lower end of the suspension block; the upper end of the suspension block is provided with a cartridge and the cartridge penetrates through the center; according to the invention, the administration structure is improved, and the injection needle tube can be stably positioned in an injection part of a patient through the trapezoidal rubber block and the medical fixing band, so that the situations of injection needle tube loosening and medicine exosmosis caused by shaking of the body of the patient can be avoided, and the stability of medicine injection can be effectively improved through rubber covering; and finally, after medicine injection is finished, the collecting module of the receiving body is inserted into the side edge of the rubber block in an inclined direction while the injection needle tube is withdrawn, so that a collecting groove of the collecting module can be in contact with the lower end of the injection needle tube, and residual medicine liquid can be collected by the collecting module when dripped out for the second time.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical devices, and more specifically to an anti-extravasation chemotherapy injector for oncology. Background Art

[0002] Oncology mainly provides conservative treatment for patients with malignant tumors. During the conservative treatment, chemotherapy drugs are accurately injected into the patient's vein through a corresponding injector, so that the drugs can effectively perform conservative chemotherapy on the tumors in the body according to the absorption of the vein. Therefore, the intervention of the injector can improve the injection effect of chemotherapy drugs; In summary, the inventor found that the existing injectors mainly have the following defects: since the current chemotherapy drugs for tumors are irritating, when the injector injects the drugs, extravasation may occur due to the shaking of the patient's body. As a result, when some drugs come into contact with the skin, it will cause skin damage and reduce the comprehensiveness of chemotherapy. Therefore, during drug administration, medical staff need to observe in real time, which will reduce the use intensity of the injector and increase the manual operation intensity. At the same time, after the injector is withdrawn from the patient's injection area, the remaining drugs in the syringe will drip again due to the pulling force during withdrawal. Affected by this phenomenon, the current injector cannot achieve a complete anti-extravasation effect. Summary of the Invention

[0003] The technical solution adopted by the present invention to achieve the technical purpose is: an anti-extravasation chemotherapy injector for oncology, the structure of which includes: a drug administration structure, the center of the upper end of the drug administration structure is fixedly connected to the lower end of a hose, and the upper end of the hose is hermetically connected to the lower end of a guiding module. The top of the guiding module is embedded in the lower end of a hanging block, and a medicine cylinder is provided at the upper end of the hanging block and the center of the medicine cylinder penetrates through it.

[0004] As a further improvement of the present invention, the drug administration structure is provided with a receiving body, the receiving body obliquely penetrates through the side parts of a rubber block and a contact layer and is in contact with an injection syringe. The injection syringe penetrates through the central area of the rubber block and is connected to the lower end of an airtight tube through the rubber block. At the same time, the upper end of the airtight tube is fixedly connected to the lower end of the hose.

[0005] As a further improvement of the present invention, the receiving body is provided with a collection module. The collection module is provided with a pull block at the center of the side, a slider is fixed at the edge area, and a collection groove is provided in the middle. The collection groove communicates with an assembly block through the other end of the collection module, and the assembly block is embedded in the opposite direction of the pull block of the collection module through the collection groove.

[0006] As a further improvement of the present invention, the trapezoidal rubber block of the drug delivery structure contacts the injection site of the patient. The syringe is stably inserted into the injection site of the patient in combination with the rubber block and the medical fixing band. After the injection is completed, the syringe is withdrawn. The receiver disposed on the side of the rubber block is inserted in an inclined orientation. The collection module of the receiver slides obliquely on the side of the rubber block in combination with the slider. At the same time, the collection groove combines with the assembly block to receive the remaining part of the drug in the syringe.

[0007] As a further improvement of the present invention, the collection module is provided with a simple connection body. The simple connection body is embedded in the surface part of the fixed block, and the fixed block is fixedly connected to the lower end of the absorbent pad through the simple connection body. At the same time, the absorbent pad coincides with the fixed block. The lower layer of the simple connection body communicates with the triangular member, and a control module is fixed at the lower end of the triangular member.

[0008] As a further improvement of the present invention, the simple connection body is arranged in a parallel orientation at the upper end of the fixed block, and the fixed block and the absorbent pad are both in the shape of "L".

[0009] As a further improvement of the present invention, the simple connection body is provided with an insertion block. The upper end of the insertion block is fixedly connected to the lower end center of the splicing ring. A thread groove is arranged inside the splicing ring and is threadedly connected to the thread block. The upper end of the thread block is welded with a puncture block, and the absorbent pad is punctured and fixed through the puncture block.

[0010] As a further improvement of the present invention, the insertion block is perpendicular to the splicing ring. The diameter of the thread groove of the splicing ring is adapted to the diameter of the thread block. The puncture block is in a solid form and is in a triangular sharp form.

[0011] As a further improvement of the present invention, the cartridge is provided with a connecting rod. The connecting rod is fixedly connected to three auxiliary discs and penetrates through the center of the cylinder cover at the upper end. The connecting rod carries the auxiliary discs into the mixing chamber of the airtight cylinder and communicates with the output disc below at the same time.

[0012] As a further improvement of the present invention, the connecting rod is fixedly cross-connected with the center of the cylinder cover. At the same time, there is a spacing between the three auxiliary discs carried by it. Thus, the mixing chamber inside the airtight cylinder is set in a vertical orientation, and the output disc is provided with a fixed output groove.

[0013] As a further improvement of the present invention, the connecting rod is provided with a restraint block. The restraint block falls on the surface edge of the solid disc, and a rod body is fixed in the center area of the solid disc. At the same time, three connecting layers are set on the edge of the rod body. The rod body completes the detachable connection with the three auxiliary discs through the three connecting layers. The solid disc is embedded in the surface part of the cylinder cover through the restraint block.

[0014] As a further improvement of the present invention, four restraint blocks are provided on the solid disk, and the solid disk and the rod body form a "T" shape. Furthermore, the three connection layers of the rod body are set in the upper, middle, and lower positions to adapt to the position of the auxiliary disk.

[0015] As a further improvement of the present invention, the cartridge is vertically arranged at the center of the upper end of the suspension block, and a rubber clamping ring is provided at the connection part between the lower end of the suspension block and the guiding module. At the same time, the guiding module is perpendicular to the hose.

[0016] As a further improvement of the present invention, the inner wall of the airtight tube is provided with a rubber threaded wall. Furthermore, the rubber block is trapezoidal in shape and is used in combination with a medical fixing band. The receiving body is arranged obliquely on the side of the rubber block and covers the lower end of the syringe needle after being fully inserted.

[0017] As a further improvement of the present invention, the center of the pulling block is provided with a groove. Rectangular sliders are provided on the left and right sides of the collecting module. The collecting groove is in a parallel concave shape and one end communicates with the assembling block. The lower end of the assembling block is provided with a clamping block.

[0018] Compared with the prior art, the present invention has the following beneficial effects: 1. After the administration structure of the present invention is further improved, the syringe needle can be stably positioned at the injection site of the patient through the trapezoidal rubber block and the medical fixing band, thus avoiding the loosening of the syringe needle and the leakage of the drug caused by the shaking of the patient's body. At the same time, the fitting contact of the rubber block can be used to replace the original solid fixing plate, preventing the pain caused by excessive squeezing of the patient's injection site. Furthermore, the rubber covering can effectively improve the stability of drug injection. Finally, after the drug injection is completed, when the syringe needle is withdrawn, the collecting module of the receiving body is inserted obliquely into the side of the rubber block. Therefore, the collecting groove of the collecting module can contact the lower end of the syringe needle. Therefore, when the syringe needle is withdrawn, the residual liquid medicine dripping out for the second time will be collected by the collecting module, completely avoiding the irritation caused by the direct contact of part of the liquid medicine dripping out for the second time with the patient's skin. Therefore, the use effect of the applicator can be further improved.

[0019] 2. After the collecting module of the present invention is further improved, the liquid medicine dripping out for the second time can be absorbed by the liquid absorbing pad installed inside, avoiding the difficult-to-handle situation caused by pooling in one place. At the same time, the liquid absorbing pad can be installed in the fixing block through a simple connecting body. Therefore, the fixing block can be stably embedded in the collecting module for overlapping use. Finally, the fixing block can be ejected from the bottom of the collecting module by the triangular part of the control module at the lower end. Therefore, the effect of non-contact disassembly of the liquid absorbing pad can be achieved, improving the convenience of replacing the liquid absorbing pad and the fixing block.

[0020] 3. After the further improvement of the cartridge of the present invention, various chemotherapy drugs can be gathered together through the mixing chamber inside the airtight cylinder, and then the connecting rod and the auxiliary disc on the cylinder cover are used for manual rotation to promote fusion, so as to improve the mixing uniformity between the drugs. Finally, after the drug injection is completed, the drug remaining on the inner wall of the airtight cylinder can be scraped upward by the edge of the auxiliary disc at the lowest end of the connecting rod, so as to improve the cleaning accuracy of the inner wall of the airtight cylinder and avoid the difficulty in cleaning caused by too small diameter size. Description of the Drawings

[0021] Figure 1 It is a schematic structural diagram of an anti-extravasation chemotherapy drug injector in oncology.

[0022] Figure 2 It is a schematic sectional view of the improved administration structure.

[0023] Figure 3 It is a schematic three-dimensional view of the improved receiver.

[0024] Figure 4 It is a schematic three-dimensional view of the internal components added to the collection module.

[0025] Figure 5 It is a schematic three-dimensional view of the improved simple connector.

[0026] Figure 6 It is a schematic three-dimensional view of the improved cartridge.

[0027] Figure 7 It is a schematic three-dimensional view of the improved connecting rod.

[0028] In the figure: cartridge - 1, suspension block - 2, guiding module - 3, hose - 4, administration structure - 5 airtight tube - 51, rubber block - 52, contact layer - 53, injection needle tube - 54, receiver - 55 pulling block - 551, collection module - 552, slider - 553, collection groove - 554, assembly block - 555 liquid absorption pad - 5521, simple connector - 5522, fixing block - 5523, triangular part - 5524, control module - 5525 insert block - 5221, splicing ring - 5222, thread groove - 5223, thread block - 5224, puncture block - 5225 output disc - 11, airtight cylinder - 12, mixing chamber - 13, auxiliary disc - 14, connecting rod - 15, cylinder cover - 16 restraining block - 151, solid disc - 152, rod body - 153, connecting layer - 154. Detailed Implementation Modes

[0029] The present invention will be further described below with reference to the accompanying drawings: Embodiment 1: Figures 1 to 5 As shown in the figure: The present invention provides an anti-extravasation chemotherapy drug dispenser for oncology, whose structure includes a drug delivery structure 5. The center of the upper end of the drug delivery structure 5 is fixedly connected to the lower end of a hose 4, and the upper end of the hose 4 is hermetically connected to the lower end of a guiding module 3. The top of the guiding module 3 is embedded in the lower end of a hanging block 2, and a medicine cylinder 1 is provided at the upper end of the hanging block 2 and the center of the hanging block 2 penetrates through the medicine cylinder 1.

[0030] Among them, the drug delivery structure 5 is provided with a receiving body 55. The receiving body 55 obliquely penetrates through the side parts of a rubber block 52 and a contact layer 53 and contacts an injection needle tube 54. The injection needle tube 54 penetrates through the central area of the rubber block 52 and is connected to the lower end of an airtight tube 51 through the rubber block 52. At the same time, the upper end of the airtight tube 51 is fixedly connected to the lower end of the hose 4.

[0031] Among them, the receiving body 55 is provided with a collection module 552. A pull block 551 is provided at the center of the side of the collection module 552, a slider 553 is fixed at the edge area, and a collection groove 554 is provided in the middle part. The collection groove 554 communicates with an assembly block 555 through the other end of the collection module 552. The assembly block 555 is embedded in the collection module 552 at the opposite position of the pull block 551 through the collection groove 554.

[0032] Among them, the trapezoidal rubber block 52 of the drug delivery structure 5 contacts the injection site of the patient. The injection needle tube 54 is stably inserted into the injection site of the patient in combination with the rubber block 52 and a medical fixing band. After the injection is completed, the injection needle tube 54 is withdrawn. The receiving body 55 provided on the side of the rubber block 52 is inserted obliquely. The collection module 552 of the receiving body 55 slides obliquely on the side of the rubber block 52 in combination with the slider 553. At the same time, the collection groove 554 combines with the assembly block 555 to receive the remaining part of the drug in the injection needle tube 54.

[0033] Among them, the collection module 552 is provided with a simple connection body 5522. The simple connection body 5522 is embedded in the surface part of a fixing block 5523, and the fixing block 5523 is fixedly connected to the lower end of a liquid absorption pad 5521 through the simple connection body 5522. At the same time, the liquid absorption pad 5521 and the fixing block 5523 overlap each other. The lower layer of the simple connection body 5522 communicates with a triangular part 5524, and a control module 5525 is fixed at the lower end of the triangular part 5524.

[0034] Among them, the simple connection body 5522 is arranged parallel to the upper end of the fixing block 5523, and the fixing block 5523 and the liquid absorption pad 5521 are both in the shape of "L".

[0035] Among them, the simple connector 5522 is provided with an insertion block 5221. The upper end of the insertion block 5221 is fixedly connected to the center of the lower end of the splicing ring 5222. A threaded groove 5223 is provided inside the splicing ring 5222 and is threadedly connected to a threaded block 5224. The upper end of the threaded block 5224 is welded with a puncture block 5225, and the liquid absorption pad 5521 is punctured and fixed by the puncture block 5225.

[0036] Among them, the insertion block 5221 is perpendicular to the splicing ring 5222. The diameter of the threaded groove 5223 of the splicing ring 5222 is adapted to the diameter of the threaded block 5224. The puncture block 5225 is in a solid form and in a triangular sharp form.

[0037] Among them, the medicine cartridge 1 is arranged vertically at the center of the upper end of the suspension block 2, and a rubber clamping ring is provided at the connection part between the lower end of the suspension block 2 and the guiding module 3. At the same time, the guiding module 3 is perpendicular to the hose 4.

[0038] Among them, the inner wall of the airtight tube 51 is provided with a rubber threaded wall. Furthermore, the rubber block 52 is trapezoidal in shape and is used in combination with a medical fixing band. The receiving body 55 is arranged obliquely on the side of the rubber block 52 and covers the lower end of the syringe needle 54 after being completely inserted.

[0039] Among them, a groove is provided at the center of the pulling block 551. Rectangular sliders 553 are provided on both the left and right sides of the collection module 552. The collection groove 554 is in a parallel concave form and one end communicates with the assembly block 555. A clamping block is provided at the lower end of the assembly block 555.

[0040] The specific functions and operation procedures of this embodiment: In the present invention, after adding the corresponding chemotherapeutic drug into the cartridge 1 of the anti-extravasation chemotherapy drug delivery device in the oncology department, it can be positioned in a specific pharmacy area through the hanging block 2. Then, the guiding module 3 at the lower end of the hanging block 2 can drain the drug to the drug delivery structure 5 through the hose 3, so that the drug delivery structure 5 can inject the drug into the patient's vein area through the syringe needle 54. When the syringe needle 54 is inserted into the patient's vein, it can improve the contact stability and injection airtightness through the contact layer 53 of the rubber block 52, and then use a medical fixing band to fix it in the injection site, so as to avoid the drug extravasation caused by the detachment of the syringe needle 54 due to the shaking of the patient's body. At the same time, the syringe needle 54 can be connected to the hose 4 through the rubber thread wall on the inner wall of the airtight tube 51, preventing the permeation waste generated when the liquid medicine flows, improving the stability of the liquid medicine circulation. Furthermore, after the liquid medicine injection is completed, the syringe needle 54 is withdrawn from the vein area, and the pull block 551 of the receiver 55 is immediately controlled, so that the collection module 552 can penetrate the side of the rubber block 52 in an inclined direction through the pull block 551. During the process, the slider 553 on the edge of the collection module 552 can play an auxiliary role. Then, the collection groove 554 can be located below the syringe needle 54. Subsequently, the assembly block 555 is inserted into the other end of the collection module 552, so as to seal the other end of the collection groove 554. Therefore, when the syringe needle 54 is withdrawn, the secondary dripping of the residual liquid medicine under the influence of force will fall into the collection groove 554, so that the residual part of the liquid medicine can be collected, avoiding the adverse reactions caused by the secondary dripping of part of the liquid medicine and contacting the patient's skin. Therefore, the use intensity of the drug delivery device can be effectively improved. Subsequently, the liquid absorption pad 5521 installed inside the collection module 552 can be attached to the fixing block 5523 through the simple connection body 5522, so that it can be stably installed in the collection groove 554 in the same "L" shape as the fixing block 5523 and matched with the assembly block 555. Therefore, the cooperation of the liquid absorption pad 5521 can absorb and process the liquid medicine, avoiding the outflow from the collection groove 554 area after the assembly block 555 is opened and affecting the subsequent processing stability. Finally, when the liquid absorption pad 5521 needs to be disassembled and replaced, the control module 5525 can drive the triangular part 5524 to eject the fixing block 5523 from the bottom of the collection module 552, so that the fixing block 5523 can be separated from the collection groove 554 area together with the liquid absorption pad 5521, achieving the process of avoiding hand contact for disassembly. Then, the simple connection body 5522 can be vertically installed on the fixing block 5523 through the insertion block 5221 of the splicing ring 5222, and then the splicing with the threaded block 5224 is completed through the threaded groove 5223. Subsequently, the triangular solid puncture block 5225 on the threaded block 5224 can puncture and fix the liquid absorption pad 5521, so as to achieve the effect of rapid disassembly and assembly, improving the efficiency of subsequent precise separation.

[0041] Example 2: Figures 6 to 7 As shown in: The present invention provides an anti-extravasation chemotherapy drug dispenser for oncology, The structure thereof includes that a connecting rod 15 is provided on the medicine cylinder 1. The connecting rod 15 is fixedly connected with three auxiliary discs 14 and penetrates through the center of the cylinder cover 16 at the upper end. The connecting rod 15 carries the auxiliary discs 14 into the mixing chamber 13 of the airtight cylinder 12 and is communicated with the output disc 11 at the lower end.

[0042] Among them, the connecting rod 15 is fixedly crossed with the center of the cylinder cover 16. At the same time, there is a spacing between the three auxiliary discs 14 carried by it. Thus, the mixing chamber 13 inside the airtight cylinder 12 is set in a vertical orientation, and the output disc 11 is provided with a fixed output groove.

[0043] Among them, the connecting rod 15 is provided with a restraint block 151. The restraint block 151 falls on the surface edge of the solid disc 152, and a rod body 153 is fixed in the center area of the solid disc 152. At the same time, three connecting layers 154 are set on the edge of the rod body 153. The rod body 153 completes the detachable connection with the three auxiliary discs 4 through the three connecting layers 154. The solid disc 152 is embedded in the surface part of the cylinder cover 16 through the restraint block 151.

[0044] Among them, four restraint blocks 151 are provided on the solid disc 152 in total, and the solid disc 152 and the rod body 153 form a "T" shape. Thus, the three connecting layers 154 of the rod body 153 are set in the upper, middle and lower three positions to adapt to the positions of the auxiliary discs 14.

[0045] The specific functions and operation procedures of this embodiment: In the present invention, the airtight cylinder 12 of the cartridge 1 can vertically output the liquid medicine in the mixing chamber 13 to the guiding module 3 through the output disc 11. Then, the mixing chamber 13 of the airtight cylinder 12 can collect a variety of chemotherapy drugs. Subsequently, when the cover cylinder 16 is embedded in the top of the airtight cylinder 12, the connecting rod 15 will vertically insert into the center of the mixing chamber 13. Furthermore, the three groups of auxiliary discs 14 carried thereon can perform fixed-point rotation inside the mixing chamber 13 through the rotation effect of the cover cylinder 16 on the airtight cylinder 12. Therefore, through the cooperation of the auxiliary discs 14, the uniform fusion effect of various drugs inside can be promoted. Then, the auxiliary discs 14 are provided with multiple holes, enabling the liquid medicine to flow stably downward. Finally, after the administration is completed, some liquid medicine will remain on the inner wall of the airtight cylinder 12. Therefore, when the cover cylinder 16 is separated from the top of the airtight cylinder 12, it can carry the connecting rod 15 and rise together. Subsequently, the auxiliary disc 14 at the bottom of the connecting rod 15 will scrape the inner wall of the airtight cylinder 12 using the circular shape of its edge, so that the substances remaining on the inner wall of the airtight cylinder 12 will be scraped upward and taken out, improving the cleaning accuracy of the airtight cylinder 12 and avoiding the difficult-to-clean situation caused by the small diameter. Subsequently, the solid disc 152 of the connecting rod 15 can be parallelly embedded in the upper layer of the cover cylinder 16 through the restraint block 151 to achieve the effect of mutual overlap. Then, using the vertical solid form of the rod body 153, the three threaded connection layers 154 can be set at the upper, middle, and lower positions, enabling the three threaded connection layers 154 to load the three auxiliary discs 14 one by one in parallel, so as to achieve the effect of easy disassembly and improve the mutual parallel effect of the three solid discs 152.

[0046] Any technical solution using the technical solution described in the present invention, or designed by those skilled in the art inspired by the technical solution of the present invention to achieve the above technical effects, shall fall within the protection scope of the present invention.

Claims

1. An anti-extravasation chemotherapy drug delivery device for oncology, comprising: A drug delivery structure (5), wherein the center of the upper end of the drug delivery structure (5) is fixedly connected to the lower end of the hose (4), and the upper end of the hose (4) is airtightly connected to the lower end of the guide module (3), the top of the guide module (3) is embedded in the lower end of the hanging block (2), and the upper end of the hanging block (2) is equipped with a cartridge (1) and the center allows the cartridge (1) to pass through, characterized in that: The drug delivery structure (5) is provided with a receiving body (55), the receiving body (55) obliquely penetrates the rubber block (52), the side portion of the contact layer (53) and contacts the injection needle tube (54), the injection needle tube (54) penetrates the central area of ​​the rubber block (52) and is connected to the lower end of the airtight tube (51) through the rubber block (52), and the upper end of the airtight tube (51) is fixedly connected to the lower end of the hose (4); The receiving body (55) is provided with a collecting module (552), a pulling block (551) is provided at the center of the side of the collecting module (552), a sliding block (553) is fixed to the edge region, and a collecting groove (554) is provided in the middle portion, the collecting groove (554) is communicated with the assembling block (555) through the other end of the collecting module (552), and the assembling block (555) is embedded in the opposite direction of the pulling block (551) of the collecting module (552) through the collecting groove (554); The trapezoidal rubber block (52) of the drug delivery structure (5) contacts the injection site of the patient, and the injection needle tube (54) is combined with the rubber block (52) and the medical fixing belt to stably insert into the injection site of the patient. After the injection is completed, the injection needle tube (54) is withdrawn, and the receiving body (55) arranged on the side of the rubber block (52) is inserted in an inclined position. The collecting module (552) of the receiving body (55) is combined with the slider (553) to slide obliquely on the side of the rubber block (52), and at the same time, the collecting groove (554) is combined with the assembly block (555) to receive the part of the medicine remaining in the injection needle tube (54).

2. The anti-extravasation chemotherapy drug delivery device for oncology according to claim 1, characterized in that: The collecting module (552) is provided with a simple connecting body (5522), the simple connecting body (5522) is embedded in the surface of the fixing block (5523), and the fixing block (5523) is fixedly connected with the lower end of the liquid absorbing pad (5521) through the simple connecting body (5522), and the liquid absorbing pad (5521) and the fixing block (5523) overlap with each other, the lower layer of the simple connecting body (5522) is connected to the triangular piece (5524), and the control module (5525) is fixed to the lower end of the triangular piece (5524); The simple connecting body (5522) is arranged in a parallel position at the upper end of the fixing block (5523), and the fixing block (5523) and the liquid absorbing pad (5521) have the same shape, that is, an "L" shape.

3. The anti-extravasation chemotherapy drug delivery device for oncology according to claim 2, characterized in that: The simple connection body (5522) is provided with an insert block (5221), the upper end of the insert block (5221) is fixedly connected to the center of the lower end of the splicing ring (5222), the inner layer of the splicing ring (5222) is provided with a thread groove (5223) and is threadedly connected to the thread block (5224), and a puncture block (5225) is welded to the upper end of the thread block (5224), and the liquid absorbent pad (5521) is punctured and fixed by the puncture block (5225); The insert block (5221) and the splicing ring (5222) are perpendicular to each other, the diameter of the thread groove (5223) of the splicing ring (5222) and the diameter of the thread block (5224) are mutually adapted, and the puncture block (5225) is solid and has a triangular sharp shape.

4. The anti-extravasation chemotherapy drug delivery device for oncology according to claim 1, characterized in that: The cartridge (1) is provided with a connecting rod (15), the connecting rod (15) being fixedly connected to the three auxiliary disks (14) and having its upper end passing through the center of the cartridge cover (16); the connecting rod (15) carries the auxiliary disks (14) into the mixing chamber (13) of the airtight cartridge (12) and is in communication with the output disk (11) at its lower end; The connecting rod (15) and the cylinder cover (16) are fixed to each other at the center of the circle, and there is a spacing between the three auxiliary disks (14) carried, so that the mixing chamber (13) inside the airtight cylinder (12) is set in a vertical orientation, and the output disk (11) is provided with a fixed output groove.

5. The anti-extravasation chemotherapy drug delivery device for oncology according to claim 4, characterized in that: The connecting rod (15) is provided with a restraining block (151), the restraining block (151) falls into the surface edge of the solid disk (152), and a rod body (153) is fixed in the center area of ​​the solid disk (152), and three connection layers (154) are set on the edge of the rod body (153), and the rod body (153) is detachably connected to the three auxiliary disks (4) through the three connection layers (154), and the solid disk (152) is embedded in the surface part of the cylinder cover (16) through the restraining block (151); The restraining blocks (151) are provided with four blocks on the solid disk (152), and the solid disk (152) and the rod body (153) form a "T" shape, and the three connecting layers (154) of the rod body (153) are set at the upper, middle and lower positions to match the position of the auxiliary disk (14).

6. The anti-extravasation chemotherapy drug delivery device for oncology according to claim 1, characterized in that: The cartridge (1) is arranged in a vertical position at the center of the upper end of the hanging block (2), and a rubber clamp ring is provided at the connection portion between the lower end of the hanging block (2) and the guide module (3), while the guide module (3) and the hose (4) are perpendicular to each other.

7. The anti-extravasation chemotherapy drug delivery device for oncology according to claim 1, characterized in that: The inner wall of the airtight tube (51) carries a rubber threaded wall, and the rubber block (52) is trapezoidal in shape and is used in combination with a medical fixing belt. The receiving body (55) is arranged at an inclined position on the side of the rubber block (52) and covers the lower end of the injection needle tube (54) after it is fully inserted.

8. The anti-extravasation chemotherapy drug delivery device for oncology according to claim 1, characterized in that: The pulling block (551) has a groove in the center, and the left and right sides of the collecting module (552) are equipped with rectangular sliding blocks (553). The collecting groove (554) is in a parallel concave shape and one end is connected to the assembly block (555). The lower end of the assembly block (555) has a clamping block.